{"id":254715,"title":"Notice to Stakeholders – Clarification of Requirements under the Food and Drug Regulations and the Controlled Drugs and Substances Act When Conducting Clinical Research with Psilocybin - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T13:20:05.512000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-clarification-requirements-conducting-clinical-research-psilocybin.html?wbdisable=false","snippet":"Notice to Stakeholders – Clarification of Requirements under the Food and Drug Regulations and the Controlled Drugs and Substances Act When Conducting Clinical Research with Psilocybin - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr /…","rawSnapshotUrl":"/api/snapshots/raw/254715","browseUrl":"https://replay.healtharchive.ca/job-1/20250418132005/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-clarification-requirements-conducting-clinical-research-psilocybin.html?wbdisable=false#ha_snapshot=254715","mimeType":"text/html","statusCode":200}